DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will sit on a panel at the 2007 BIO International Convention titled “Mining for Gold: Top Biotech Venture Capital Markets” in Boston
News | 05. 06. 2007
